{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:01:31Z","timestamp":1791237691470,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,27]]},"DOI":"10.1097\/tp.0b013e318250fc62","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T07:19:08Z","timestamp":1338362348000},"page":"1245-1251","source":"Crossref","is-referenced-by-count":22,"title":["Inhibitory Effect of Tacrolimus on p38 Mitogen-Activated Protein Kinase Signaling in Kidney Transplant Recipients Measured by Whole-Blood Phosphospecific Flow Cytometry"],"prefix":"10.1097","volume":"93","author":[{"given":"Ramin","family":"Vafadari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M.","family":"Cadogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Weimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla C.","family":"Baan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist.","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 1","key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1111\/j.1365-2125.2001.00365.x","article-title":"Immunosuppressant drugsthe role of therapeutic drug monitoring.","volume":"52","author":"Johnston","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/138161210790112782","article-title":"Individualizing calcineurin inhibitor therapy in renal transplantationcurrent limitations and perspectives.","volume":"16","author":"Press","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"4","key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semnephrol.2007.03.002","article-title":"Immunosuppressive strategies to improve outcomes of kidney transplantation.","volume":"27","author":"Tang","year":"2007","journal-title":"Semin Nephrol"},{"issue":"3","key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2133\/dmpk.23.150","article-title":"Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.","volume":"23","author":"Yano","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/FTD.0b013e3181c0eecb","article-title":"Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives.","volume":"32","author":"van Rossum","year":"2010","journal-title":"Ther Drug Monit"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function.","volume":"15","author":"Rao","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2174\/1568026033451916","article-title":"Regulation of MAPK signaling pathways through immunophilin-ligand complex.","volume":"3","author":"Matsuda","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1600-065X.2003.00019.x","article-title":"JNK and p38 MAP kinases in CD4 and CD8 T cells.","volume":"192","author":"Rincon","year":"2003","journal-title":"Immunol Rev"},{"issue":"4","key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ni0405-368","article-title":"MAPK p38: alternative and nonstressful in T cells.","volume":"6","author":"Rudd","year":"2005","journal-title":"Nat Immunol"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response.","volume":"20","author":"Dong","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/cimm.1998.1448","article-title":"A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production.","volume":"192","author":"Koprak","year":"1999","journal-title":"Cell Immunol"},{"issue":"5","key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1034\/j.1600-6143.2003.00123.x","article-title":"T-cell allorecognition and transplant rejection: a summary and update.","volume":"3","author":"Heeger","year":"2003","journal-title":"Am J Transplant"},{"issue":"6","key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (FK506): molecular and cellular mechanisms.","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther Drug Monit"},{"issue":"15","key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft.","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"R43-8-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1050-1738(00)00021-9","article-title":"Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression.","volume":"9","author":"Mehta","year":"1999","journal-title":"Trends Cardiovasc Med"},{"key":"R44-8-20210129","doi-asserted-by":"crossref","first-page":"821615","DOI":"10.1155\/2011\/821615","article-title":"The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis.","volume":"2011","author":"Manna","year":"2011","journal-title":"J Signal Transduct"},{"issue":"2","key":"R49-8-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.smim.2009.02.003","article-title":"Biochemical signaling pathways for memory T cell recall.","volume":"21","author":"Farber","year":"2009","journal-title":"Semin Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201206270-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T21:30:46Z","timestamp":1713994246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201206270-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,27]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318250fc62","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,27]]}}}